文献速递心外重症与机械循环支持先天性心脏病外科

Fontan术后儿童体外膜氧合支持结局分析

Extracorporeal membrane oxygenation in children after Fontan operation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-08-13

基于体外生命支持组织登记库的回顾性队列分析,纳入2010至2023年281例Fontan术后接受ECMO的18岁以下患儿,出院存活率为48.4%。ECMO前心搏骤停、碳酸氢钠使用、较高ECMO流量、较长ECMO时长、较长入院至置管时间及神经、肾脏、肺部并发症为住院死亡独立预测因素。

要点

  • Fontan术后儿童ECMO出院存活率48.4%,较既往报告改善
  • 避免ECMO前心搏骤停与更早置管可能是可改善预后的可干预因素
  • 多引流管与Fontan通路减压策略与存活无差异

核心结论

  • Fontan术后儿童ECMO的住院存活较既往报告改善,避免ECMO前心搏骤停和更早置管是可能改善结局的可干预因素。

研究设计与样本

  • 回顾性队列分析,基于体外生命支持组织登记库,纳入2010至2023年281例18岁以下Fontan术后住院期间首次ECMO运行的患儿。

主要发现

  • 出院存活率为48.4%;中位年龄3.9岁(IQR 2.7-5.5),中位体重15 kg(IQR 12-19)。
  • 静脉-动脉ECMO占92%,多引流管占21%,中心置管占49%,Fontan通路减压占51%。
  • 住院死亡独立预测因素包括ECMO前心搏骤停(OR 1.88,P=.042)、ECMO前碳酸氢钠给药(OR 2.01,P=.019)、4小时ECMO流量较高(OR 1.01,P=.014)、ECMO时长较长(OR 1.09,P=.002)、入院至置管时间较长(OR 1.04,P=.002),以及神经(OR 5.99,P<.001)、肾脏(OR 2.92,P=.005)、肺部并发症(OR 13.07,P=.022)。
  • 8例ECMO后转为心室辅助装置支持,6例接受心脏移植,两组存活率均为50%。

关键数值与推荐

  • 多引流管使用与Fontan通路减压策略对存活无差异。

临床怎么用

  • 对Fontan术后需要ECMO的患儿,应尽量避免ECMO前心搏骤停并尽早置管,以可能改善住院存活。

局限性

  • 为登记库回顾性分析,需前瞻性研究进一步明确该人群ECMO的时机、结局和最佳支持策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the outcomes of pediatric patients requiring extracorporeal membrane oxygenation (ECMO) after the Fontan operation. METHODS: We conducted a retrospective cohort analysis of the Extracorporeal Life Support Organization registry, including patients <18 years who underwent ECMO after Fontan palliation from 2010 to 2023. Patients undergoing a first ECMO run during their hospitalization for Fontan surgery were included. RESULTS: Among 281 children undergoing ECMO after Fontan palliation, survival at hospital discharge was 48.4%. Median age and weight were 3.9 years (interquartile range [IQR], 2.7-5.5) and 15 kg (IQR, 12-19), respectively. Venoarterial ECMO was used in 92% of patients, multiple drainage cannulas in 21%, central cannulation in 49%, and Fontan pathway decompression in 51%. Survival did not differ according to the use of multiple drainage cannulas or decompression strategy. Independent predictors of hospital mortality included pre-ECMO arrest (odds ratio [OR], 1.88; P = .042), pre-ECMO bicarbonate administration (OR, 2.01; P = .019), higher ECMO flow at 4 hours (OR, 1.01; P = .014), longer ECMO duration (OR, 1.09; P = .002), longer admission-to-cannulation time (OR, 1.04; P = .002), and neurologic (OR, 5.99; P < .001), renal (OR, 2.92; P = .005), or pulmonary complications (OR, 13.07; P = .022). Eight patients were transitioned to ventricular assist device support after ECMO, and 6 underwent heart transplantation; survival in both groups was 50%. CONCLUSIONS: Hospital survival after ECMO following Fontan palliation has improved compared with prior reports. The avoidance of pre-ECMO arrest and earlier cannulation are potentially modifiable factors that may improve outcomes for these patients. Prospective studies are warranted to better define the timing, outcomes, and optimal support strategies in this population.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Anton-Martin P, Cardoso Cavalcante R, Master L, et al. Extracorporeal membrane oxygenation in children after Fontan operation. J Thorac Cardiovasc Surg. 2026. PMID: 42595216. doi:10.1016/j.jtcvs.2026.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。